+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Imaging System Market by Product Type, Application, Technology, End User - Global Forecast to 2030- Product Image
Cancer Imaging System Market by Product Type, Application, Technology, End User - Global Forecast to 2030- Product Image
Sale

Cancer Imaging System Market by Product Type, Application, Technology, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014726
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cancer Imaging System Market grew from USD 20.16 billion in 2024 to USD 22.18 billion in 2025. It is expected to continue growing at a CAGR of 9.62%, reaching USD 34.99 billion by 2030.

Pioneering the Future of Cancer Imaging with Unmatched Precision

Cancer imaging stands at the forefront of an era defined by rapid technological progress and heightened clinical demand. This executive summary opens with a concise exploration of the trends shaping diagnostic and therapeutic decision-making, underscoring the indispensable role of advanced imaging modalities in delivering precise, patient-centric care. As diagnostic confidence becomes non-negotiable, stakeholders across the value chain-from equipment vendors to healthcare providers-must navigate evolving clinical guidelines, regulatory pathways, and reimbursement landscapes. Transitional drivers such as integrated workflows and data-driven performance benchmarks are raising the bar, prompting organizations to reassess their portfolios and strategic roadmaps. By contextualizing current market forces and clinical imperatives, this introduction lays the groundwork for a deeper dive into the shifts, impacts, and strategic insights that define the cancer imaging market today and chart its trajectory tomorrow.

Emerging Paradigms Redefining Diagnostic and Therapeutic Imaging

The cancer imaging landscape is undergoing transformative shifts as artificial intelligence algorithms mature, hybrid imaging systems become more accessible, and contrast agents evolve to enhance lesion characterization. Across modalities such as computed tomography and magnetic resonance imaging, dual-energy techniques and advanced reconstructions are unlocking new anatomical and functional insights. Concurrently, the integration of three-dimensional visualization tools is empowering clinicians to plan interventions with unprecedented clarity, while workflow management platforms driven by computer-aided detection and diagnosis streamline processes, reduce variability, and accelerate time to treatment. Hybrid imaging combinations like PET-CT and PET-MRI are redefining diagnostic accuracy by merging metabolic and structural data, and ultrasound innovations-including Doppler analysis and four-dimensional scanning-are expanding the scope of noninvasive evaluation. These converging developments herald a new paradigm in which synergistic technological advancements and cross-functional collaboration propel personalized oncology care into a data-rich, efficiency-driven future.

Navigating the 2025 US Tariffs: Implications for Cancer Imaging Ecosystem

The introduction of revised tariffs in mid-2025 has recalibrated cost structures across the cancer imaging ecosystem, particularly impacting equipment imported into the United States. Devices ranging from multi-slice computed tomography and closed magnetic resonance imaging units to PET-CT hybrid scanners now bear increased duties, compelling manufacturers and distributors to optimize supply chains and reconsider pricing strategies. Concurrently, contrast agent suppliers for CT, MRI, and ultrasound are evaluating novel formulations and domestic manufacturing partnerships to mitigate margin erosion. Importers must also navigate complex customs regulations and leverage tariff mitigation instruments, such as bonded warehousing and advanced rulings. While short-term headwinds have strained procurement budgets for hospitals, clinics, and diagnostic centers, proactive contract renegotiations and strategic inventory planning have partially offset the burden. Looking ahead, organizations that embrace localization initiatives and strategic tariff hedging will be better positioned to maintain competitive pricing while sustaining technology adoption rates across academic research institutes and private healthcare facilities.

Deep Dive into Product, Application, Technology, and End User Dynamics

A nuanced understanding of product type dynamics reveals that computed tomography systems-spanning cone beam, dual source, and multi-slice variants-remain central to oncology diagnostics due to their high resolution and rapid acquisition times. Digital radiography solutions backed by flat panel detectors and charged coupled devices continue to serve as cost-effective screening tools, while the ongoing refinement of closed, open, and extremity magnetic resonance imaging enhances patient comfort and lesion discernment. Positron emission tomography applications, from PET-CT to PET-MRI, deliver unparalleled metabolic mapping, and ultrasound modalities equipped with two-dimensional, Doppler, and three- to four-dimensional capabilities provide real-time insights during interventional procedures. On the application front, imaging for breast, colorectal, lung, and prostate cancers depicts diverse demands in sensitivity, throughput, and workflow integration. Technological segmentation shows that artificial intelligence solutions-encompassing computer-aided detection, computer-aided diagnosis, and workflow management-complement contrast imaging agents tailored for CT, MRI, and ultrasound. Hybrid imaging combinations, whether PET-CT, PET-MRI, or SPECT-CT, elevate diagnostic confidence, and three-dimensional visualization techniques such as maximum intensity projection, surface rendering, and volume rendering enrich preoperative planning. End users spanning academic research institutes, clinics, diagnostic imaging centers, and hospitals each exhibit unique adoption curves, driven by budgetary constraints, clinical expertise, and patient volumes. This layered segmentation insight underscores the importance of targeted investments and strategic alliances to capture value across the cancer imaging continuum.

Regional Market Trajectories Shaping Global Growth Patterns

The Americas market continues to lead in adoption of next-generation imaging systems, buoyed by robust healthcare infrastructure, favorable reimbursement policies, and concentrated academic research hubs that drive clinical validation of emerging modalities. In the Europe, Middle East & Africa region, diversified healthcare maturity levels spur differentiated demand: Western European nations accelerate uptake of hybrid imaging and AI-augmented platforms, while emerging markets in the Middle East and Africa prioritize cost-effective solutions such as digital radiography and open MRI. Asia-Pacific demonstrates rapid growth, underpinned by large patient populations, government initiatives to expand diagnostic reach, and increasing partnerships between local manufacturers and global technology providers. Domestic innovation is particularly pronounced in countries investing in scanner manufacturing capabilities and bespoke contrast agents. Regional dynamics also reflect divergent regulatory environments; harmonized pathways in certain jurisdictions facilitate market entry, whereas protracted approval processes in others necessitate strategic planning and localized clinical studies. These regional insights highlight the necessity for adaptive market strategies tailored to each geography’s distinct regulatory, economic, and infrastructural contours.

Competitive Landscape and Strategic Positioning of Leading Innovators

Key players at the forefront of cancer imaging innovation encompass a blend of multinational corporations and specialized technology firms. Leading suppliers of computed tomography, magnetic resonance, and hybrid imaging platforms continuously refine hardware and software integration to sustain their market share. Some have leveraged strategic acquisitions to bolster their artificial intelligence and three-dimensional visualization portfolios, while others have forged alliances with contrast agent manufacturers to deliver end-to-end imaging solutions. A subset of innovators excels in ultrasound advancements, expanding the modality’s role in both diagnostic and interventional oncology applications. Concurrently, new entrants harness open architecture platforms to facilitate seamless interoperability with electronic medical records and picture archiving systems, elevating workflow efficiency. These market leaders also prioritize sustainability initiatives, integrating energy-efficient designs and eco-friendly materials to align with global environmental standards. By balancing R&D investment with strategic partnerships and service excellence, these companies fortify their competitive positioning and shape the evolution of the cancer imaging landscape.

Strategic Imperatives for Driving Sustainable Competitive Advantage

Industry leaders must adopt a dual focus on technology integration and value-based care to secure long-term growth. Investing in artificial intelligence algorithms that seamlessly plug into existing imaging infrastructures can reduce diagnostic variability and optimize patient throughput. Collaborating with contrast agent developers to co-innovate next-generation tracers will enhance lesion differentiation and expand indications. Establishing localized manufacturing or assembly operations in key markets can mitigate tariff impacts and strengthen supply chain resilience. Furthermore, developing tiered service models that bundle training, maintenance, and software upgrades will improve customer retention and generate recurring revenue streams. Engaging in multi-stakeholder partnerships with hospitals, research institutes, and payers will accelerate clinical validation and secure reimbursement approvals. Leadership teams should also track evolving regulatory frameworks and cultivate dedicated compliance functions to expedite market entry for novel devices. By aligning strategic imperatives with a deep understanding of end-user needs-whether in high-volume hospitals or resource-constrained clinics-companies can tailor offerings that deliver measurable clinical and economic value.

Rigorous Framework Underpinning Comprehensive Market Analysis

This report synthesizes both primary and secondary research methodologies to ensure a comprehensive and unbiased analysis. Primary data collection involved in-depth interviews with C-suite executives, clinical experts, and procurement specialists across diverse healthcare settings. Secondary research incorporated peer-reviewed journals, regulatory filings, company annual reports, and proprietary databases to validate market trends and technology adoption rates. Data triangulation techniques were employed to reconcile discrepancies and corroborate insights from multiple sources. Quantitative inputs on device shipments, application volumes, and reimbursement policies were analyzed alongside qualitative assessments of competitive strategies and regulatory barriers. Geographic coverage spanned key markets in the Americas, Europe, Middle East & Africa, and Asia-Pacific, with localized validation conducted through expert panels. Methodological rigor was maintained through iterative reviews, cross-functional workshops, and adherence to industry best practices in market intelligence, ensuring that findings are both robust and actionable.

Synthesizing Insights to Illuminate the Path Forward

The collective insights presented herein illuminate the intricate interplay between technological innovation, regulatory dynamics, and market demand in the cancer imaging sector. From the microcosm of product subsegments to the macro forces of regional trade policies, each dimension contributes to a multifaceted growth narrative. By understanding how tariff adjustments, clinical adoption patterns, and competitive maneuvers converge, stakeholders can make informed decisions that drive both clinical excellence and financial performance. Anticipating future shifts-whether in artificial intelligence capabilities, hybrid imaging modalities, or reimbursement landscapes-will be critical to maintaining a leadership stance. Ultimately, the ability to translate data-driven insights into strategic action will determine which organizations seize the growth opportunities inherent in the evolving cancer imaging market.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Computed Tomography
      • Cone Beam Computed Tomography
      • Dual Source Computed Tomography
      • Multi Slice Computed Tomography
    • Digital Radiography
      • Charged Coupled Device
      • Flat Panel Detector
    • Magnetic Resonance Imaging
      • Closed Magnetic Resonance Imaging
      • Extremity Magnetic Resonance Imaging
      • Open Magnetic Resonance Imaging
    • Positron Emission Tomography
      • PET CT
      • PET MRI
    • Ultrasound
      • Doppler Analysis
      • Three D Four D Analysis
      • Two D Analysis
  • Application
    • Breast Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Prostate Cancer
  • Technology
    • Artificial Intelligence
      • Computer Aided Detection
      • Computer Aided Diagnosis
      • Workflow Management
    • Contrast Imaging
      • CT Contrast Agents
      • MRI Contrast Agents
      • Ultrasound Contrast Agents
    • Hybrid Imaging
      • PET CT Hybrid
      • PET MRI Hybrid
      • SPECT CT Hybrid
    • Three D Visualization
      • Max Intensity Projection
      • Surface Rendering
      • Volume Rendering
  • End User
    • Academic Research Institutes
    • Clinics
    • Diagnostic Imaging Centers
    • Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • GE HealthCare Technologies, Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Hitachi, Ltd.
  • Shimadzu Corporation
  • Konica Minolta, Inc.
  • Samsung Medison Co., Ltd.
  • Hologic, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cancer Imaging System Market, by Product Type
8.1. Introduction
8.2. Computed Tomography
8.2.1. Cone Beam Computed Tomography
8.2.2. Dual Source Computed Tomography
8.2.3. Multi Slice Computed Tomography
8.3. Digital Radiography
8.3.1. Charged Coupled Device
8.3.2. Flat Panel Detector
8.4. Magnetic Resonance Imaging
8.4.1. Closed Magnetic Resonance Imaging
8.4.2. Extremity Magnetic Resonance Imaging
8.4.3. Open Magnetic Resonance Imaging
8.5. Positron Emission Tomography
8.5.1. PET CT
8.5.2. PET MRI
8.6. Ultrasound
8.6.1. Doppler Analysis
8.6.2. Three D Four D Analysis
8.6.3. Two D Analysis
9. Cancer Imaging System Market, by Application
9.1. Introduction
9.2. Breast Cancer
9.3. Colorectal Cancer
9.4. Lung Cancer
9.5. Prostate Cancer
10. Cancer Imaging System Market, by Technology
10.1. Introduction
10.2. Artificial Intelligence
10.2.1. Computer Aided Detection
10.2.2. Computer Aided Diagnosis
10.2.3. Workflow Management
10.3. Contrast Imaging
10.3.1. CT Contrast Agents
10.3.2. MRI Contrast Agents
10.3.3. Ultrasound Contrast Agents
10.4. Hybrid Imaging
10.4.1. PET CT Hybrid
10.4.2. PET MRI Hybrid
10.4.3. SPECT CT Hybrid
10.5. Three D Visualization
10.5.1. Max Intensity Projection
10.5.2. Surface Rendering
10.5.3. Volume Rendering
11. Cancer Imaging System Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Clinics
11.4. Diagnostic Imaging Centers
11.5. Hospitals
12. Americas Cancer Imaging System Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cancer Imaging System Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cancer Imaging System Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. GE HealthCare Technologies, Inc.
15.3.2. Siemens Healthineers AG
15.3.3. Koninklijke Philips N.V.
15.3.4. Canon Medical Systems Corporation
15.3.5. Fujifilm Holdings Corporation
15.3.6. Hitachi, Ltd.
15.3.7. Shimadzu Corporation
15.3.8. Konica Minolta, Inc.
15.3.9. Samsung Medison Co., Ltd.
15.3.10. Hologic, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CANCER IMAGING SYSTEM MARKET MULTI-CURRENCY
FIGURE 2. CANCER IMAGING SYSTEM MARKET MULTI-LANGUAGE
FIGURE 3. CANCER IMAGING SYSTEM MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CANCER IMAGING SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CANCER IMAGING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CANCER IMAGING SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONE BEAM COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DUAL SOURCE COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MULTI SLICE COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CHARGED COUPLED DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY FLAT PANEL DETECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CLOSED MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY EXTREMITY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY OPEN MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DOPPLER ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D FOUR D ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY TWO D ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTER AIDED DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTER AIDED DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY WORKFLOW MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CT CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MRI CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET CT HYBRID, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PET MRI HYBRID, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SPECT CT HYBRID, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAX INTENSITY PROJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SURFACE RENDERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY VOLUME RENDERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 89. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 91. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 92. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 93. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 94. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 95. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 98. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 99. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 100. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 101. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 104. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 105. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 106. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 107. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 108. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 111. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 112. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 113. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 114. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 170. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 171. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 172. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 173. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 174. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 177. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 178. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 179. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 183. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 184. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 185. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 186. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 187. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 190. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 191. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 192. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 193. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 209. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 210. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 211. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 212. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 213. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 216. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 217. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 218. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 219. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 222. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 223. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 224. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 225. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 226. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 229. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 230. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 231. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 232. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 256. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 270. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 273. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 274. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 275. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 276. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 277. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 278. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 281. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 282. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 283. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 284. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 300. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 301. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 302. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 303. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 304. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTELLIGENCE, 2018-2030 (USD MILLION)
TABLE 307. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY CONTRAST IMAGING, 2018-2030 (USD MILLION)
TABLE 308. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY HYBRID IMAGING, 2018-2030 (USD MILLION)
TABLE 309. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY THREE D VISUALIZATION, 2018-2030 (USD MILLION)
TABLE 310. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 313. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY DIGITAL RADIOGRAPHY, 2018-2030 (USD MILLION)
TABLE 314. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 315. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 316. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 317. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 319. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY ARTIFICIAL INTE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cancer Imaging System market report include:
  • GE HealthCare Technologies, Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • Hitachi, Ltd.
  • Shimadzu Corporation
  • Konica Minolta, Inc.
  • Samsung Medison Co., Ltd.
  • Hologic, Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 22.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 34.99 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Next-Generation Oncology Devices & Solutions Market by Device Type, Technology, Cancer Type, End User - Global Forecast to 2030 - Product Image

Next-Generation Oncology Devices & Solutions Market by Device Type, Technology, Cancer Type, End User - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Molecular Imaging Market Size, Share, & Trends Analysis Report by Modality (Molecular Ultrasound Imaging, Positron Emission Tomography), Application (Cardiovascular, Neurology), End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Molecular Imaging Market Size, Share, & Trends Analysis Report by Modality (Molecular Ultrasound Imaging, Positron Emission Tomography), Application (Cardiovascular, Neurology), End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
North America Mobile and Fixed Medical Imaging Services Market Size, Share & Trends Analysis Report by Technology (Mobile & Interim Imaging Services, Fixed Radiology Services), Application, End Use, Country, with Growth Forecasts, 2025-2030 - Product Image

North America Mobile and Fixed Medical Imaging Services Market Size, Share & Trends Analysis Report by Technology (Mobile & Interim Imaging Services, Fixed Radiology Services), Application, End Use, Country, with Growth Forecasts, 2025-2030

  • Report
  • 175 Pages
  • North America
From
Diagnostic Imaging Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Diagnostic Imaging Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
UAE Nuclear Imaging Equipment Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

UAE Nuclear Imaging Equipment Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 75 Pages
  • United Arab Emirates United Arab Emirates
From

About the Cancer Imaging System Market

The Cancer Imaging System market is a subset of the Medical Imaging market, which is used to diagnose and treat diseases. It is composed of a variety of imaging technologies, such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and positron emission tomography (PET). These technologies are used to detect and monitor cancer, as well as to plan and evaluate treatments. Cancer Imaging Systems are used to detect and diagnose cancer, as well as to monitor the progress of treatment. They can also be used to detect and monitor metastases, or the spread of cancer to other parts of the body. Some companies in the Cancer Imaging System market include GE Healthcare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems, Hitachi Medical Systems, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.